Symrise stock trades near Xetra close after 2026 outlook reaffirmed
Published on 11/05/2026 at 17:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- Third-quarter organic sales growth reached 5.3 percent, driven mainly by volume across both operating segments.
- Symrise reaffirmed its 2026 targets but expects slower fourth-quarter growth against tougher comparisons.
- Planned reinvestment in IT, innovation and people is expected to keep the adjusted EBITDA margin in the lower half of its target range.
Symrise stock traded at 97.90 euros on Lang & Schwarz at 17:47 CET on Thursday, November 5, 2026, 0.06 percent below the Xetra close of Thursday, November 5, at 97.96 euros. Compared with the 93.24-euro quote used in the previous report on November 4, the latest price is 5.00 percent higher. The comparison reflects the latest market level and does not establish a causal link to the company's operating update.
The latest operating update came on October 28, when Symrise reported 5.3 percent organic sales growth in the third quarter of 2026. The company said growth was predominantly volume-driven, with both operating segments contributing and Pet Food and Care & Wellness returning to growth.
Growth broadens across segments
Taste, Nutrition & Health posted 5.2 percent organic growth, with reported sales of 790 million euros versus 736 million euros a year earlier. Scent & Care grew organically by 5.6 percent, while reported sales reached 520 million euros compared with 487 million euros in the prior-year quarter. Group sales increased to 1,310 million euros from 1,222 million euros.
For the first nine months, group sales totaled 3,850 million euros and organic growth was 3.0 percent. Symrise also said the ONE SYM Transformation had moved from organizational redesign into implementation, with commercial excellence, innovation, scale benefits and digitalization among its priorities.
Outlook stays intact, margins in focus
Symrise kept its 2026 targets for organic sales growth of 2 to 4 percent, an adjusted EBITDA margin of 21.5 to 22.5 percent and an adjusted business free cash flow margin above 14 percent. Management expects full-year organic growth near the midpoint of the range, while fourth-quarter growth should moderate against higher prior-year comparisons. Reinvestment in IT, innovation and people is expected to place the adjusted EBITDA margin in the lower half of the corridor.
The real-time quote of Symrise stock provides the latest market level for investors following the outlook and the next phase of the transformation.
The DAX provides the relevant German equity-market backdrop for investors following Symrise.
Current market reports offer broader context, while more news and analyses on Symrise stock track further company developments. Symrise's next scheduled investor event is a European Conference in London on November 10, 2026.
Symrise AG at a glance
- Company: Symrise AG
- ISIN: DE000SYM9999
- Xetra ticker: SY1.DE
- Lang & Schwarz quote: 97.90 euros at 17:47 CET on November 5, 2026
- Change versus Xetra close: 0.06 percent below the 97.96-euro close on November 5, 2026
- Latest operating update: Third quarter of 2026
